Islet autoimmunity and HLA markers of presymptomatic and clinical type 1 diabetes: joint analyses of prospective cohort studies in Finland, Germany, Sweden, and the U.S
Open accessPublished version of a preprint
The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To combine prospective cohort studies, by including HLA harmonization, and estimate risk of islet autoimmunity and progression to clinical diabetes. RESEARCH DESIGN AND METHODS: For prospective cohorts in Finland, Germany, Sweden, and the U.S., 24,662 children at increased genetic risk for development of islet autoantibodies and type 1 diabetes have been followed. Following harmonization, the outcomes were analyzed in 16,709 infants-toddlers enrolled by age 2.5 years. RESULTS: In the infant-toddler cohort, 1,413 (8.5%) developed at least one autoantibody confirmed at two or more consecutive visits (seroconversion), 865 (5%) developed multiple autoantibodies, and 655 (4%) progressed to diabetes. The 15-year cumulative incidence of diabetes varied in children with one, two, or three autoantibodies at seroconversion: 45% (95% CI 40–52), 85% (78–90), and 92% (85–97), respectively. Among those with a single autoantibody, status 2 years after seroconversion predicted diabetes risk: 12% (10–25) if reverting to autoantibody negative, 30% (20–40) if retaining a single autoantibody, and 82% (80–95) if developing multiple autoantibodies. HLA-DR-DQ affected the risk of confirmed seroconversion and progression to diabetes in children with stable single-autoantibody status. Their 15-year diabetes incidence for higher- versus lower-risk genotypes was 40% (28–50) vs. 12% (5–38). The rate of progression to diabetes was inversely related to age at development of multiple autoantibodies, ranging from 20% per year to 6% per year in children developing multipositivity in ≤2 years or >7.4 years, respectively. CONCLUSIONS: The number of islet autoantibodies at seroconversion reliably predicts 15-year type 1 diabetes risk. In children retaining a single autoantibody, HLA-DR-DQ genotypes can further refine risk of progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of multiple islet autoantibodies (IAA, GADA, IA-2A/IA-2bA, or ZnT8A) is associated with a risk of type 1 diabetes of >90% (408,422,423).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [423]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Self-citationInsel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216
Self-citationEpidemiology of type 1 diabetes
Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.011 · Cited by 1,092
HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk
Erlich, H., Valdes, A. M., Noble, J., Carlson, J. A., Varney, M., Concannon, P., Mychaleckyj, J. C., Todd, J. A., Bonella, P., Fear, A. L., et al. (2008) · Diabetes · doi:10.2337/db07-1331 · Cited by 790
Ziegler, A. G., Hummel, M., Schenker, M., & Bonifacio, E. (1999) · Diabetes · doi:10.2337/diabetes.48.3.460 · Cited by 645
Self-citationthe TEDDY Study Group, Krischer, J. P., Lynch, K. F., Schatz, D. A., Ilonen, J., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Simell, O. G., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3514-y · Cited by 444
Self-citationRewers, M., Bugawan, T. L., Norris, J. M., Blair, A., Beaty, B., Hoffman, M., McDuffie, R. S., Hamman, R. F., Klingensmith, G., Eisenbarth, G. S., et al. (1996) · Diabetologia · doi:10.1007/s001250050514 · Cited by 422
Self-citationDiabetes Antibody Standardization Program: first assay proficiency evaluation
Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1128 · Cited by 362
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Quattrin, T., Mastrandrea, L. D., & Walker, L. S. K. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00223-4 · Cited by 244
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 205
Besser, R. E. J., Bell, K. J., Couper, J., Ziegler, A., Wherrett, D. K., Knip, M., Speake, C., Casteels, K., Driscoll, K. A., Jacobsen, L. M., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13410 · Cited by 188
Self-citationHaller, M. J., Bell, K. J., Besser, R. E. J., Casteels, K., Couper, J. J., Craig, M. E., Elding Larsson, H., Jacobsen, L., Lange, K., Oron, T., et al. (2024) · Hormone Research in Paediatrics · doi:10.1159/000543035 · Cited by 151
Self-citationPhillip, M., Achenbach, P., Addala, A., Albanese-O’Neill, A., Battelino, T., Bell, K. J., Besser, R. E. J., Bonifacio, E. E., Colhoun, H. M., Couper, J., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06205-5 · Cited by 136
Self-citationKrischer, J. P., Liu, X., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Toppari, J., Ziegler, A.-G., Akolkar, B., TEDDY Study Group, et al. (2022) · Diabetes Care · doi:10.2337/dc21-2612 · Cited by 76
Self-citationPhillip, M., Achenbach, P., Addala, A., Albanese-O’Neill, A., Battelino, T., Bell, K. J., Besser, R. E. J., Bonifacio, E., Colhoun, H. M., Couper, J. J., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0042 · Cited by 79
Self-citationTwo-age islet-autoantibody screening for childhood type 1 diabetes: a prospective cohort study
Ghalwash, M. F., Dunne, J., Lundgren, M., Rewers, M., Ziegler, A., Anand, V., Toppari, J., Veijola, R., & Hagopian, W. (2022) · The Lancet Diabetes and Endocrinology · doi:10.1016/s2213-8587(22)00141-3 · Cited by 49
Self-citationFelton, J. L., REDONDO, M. J., Oram, R. A., Speake, C., Long, S. A., Önengüt-Gümüşcü, S., Rich, S. S., Monaco, G. S. F., Harris-Kawano, A., Perez, D., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00478-y · Cited by 72
Doliba, N. M., Rozo, A. V., Roman, J., Qin, W., Traum, D., Gao, L., Liu, J., Manduchi, E., Liu, C., Golson, M. L., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci156243 · Cited by 61
Hendriks, E., Marcovecchio, M. L., Besser, R. E. J., Bonifacio, E. E., Casteels, K., Larsson, H. E., Gemulla, G., Lundgren, M., Kordonouri, O., Mallone, R., et al. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3777 · Cited by 49
Self-citationKwon, B. C., Anand, V., Achenbach, P., Dunne, J. L., Hagopian, W., Hu, J., Koski, E., Lernmark, Å., Lundgren, M., Ng, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28909-1 · Cited by 44
Self-citationGhalwash, M. F., Anand, V., Lou, O., Martin, F., Rewers, M., Ziegler, A., Toppari, J., Hagopian, W., Veijola, R., Achenbach, P., et al. (2023) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(22)00350-9 · Cited by 43
Self-citationHealth economic considerations of screening for early type 1 diabetes
Rewers, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16522 · Cited by 28
Self-citationFrohnert, B. I., Ghalwash, M. F., Li, Y., Ng, K., Dunne, J. L., Lundgren, M., Hagopian, W., Lou, O., Winkler, C., Toppari, J., et al. (2023) · Diabetes Care · doi:10.2337/dc22-1960 · Cited by 27
Self-citationMallone, R., Bismuth, É., Thivolet, C. H., Benhamou, P., Hoffmeister, N., Collet, F., Nicolino, M. P., Reynaud, R., & Beltrand, J. (2024) · Diabetes & Metabolism · doi:10.1016/j.diabet.2024.101603 · Cited by 23
Ferrannini, E., Mari, A., Monaco, G. S. F., Skyler, J. S., & Evans‐Molina, C. (2022) · Diabetologia · doi:10.1007/s00125-022-05836-w · Cited by 21
Ng, K., Stavropoulos, H., Anand, V., Veijola, R., Toppari, J., Maziarz, M., Lundgren, M., Waugh, K., Frohnert, B. I., Martin, F., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0878 · Cited by 23
Self-citationExploring Minimally Invasive Approach to Define Stages of Type 1 Diabetes Remotely
Kontola, H., Alanko, I., Koskenniemi, J. J., Löyttyniemi, E., Itoshima, S., Knip, M., Veijola, R., Toppari, J., & Kero, J. T. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0554 · Cited by 19
Self-citationLind, A., Freyhult, E., Cortez, F. D. J., Ramelius, A., Bennet, R., Robinson, P. V., Seftel, D., Gebhart, D., Tandel, D., Maziarz, M., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105144 · Cited by 20
Self-citationData-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles
Ghalwash, M. F., Anand, V., Ng, K., Dunne, J. L., Lou, O., Lundgren, M., Hagopian, W., Rewers, M., Ziegler, A. G., Veijola, R., et al. (2024) · Diabetes Care · doi:10.2337/dc24-0198 · Cited by 19
Self-citationLamichhane, S., Sen, P., Dickens, A. M., Kråkström, M., Ilonen, J., Lempainen, J., Hyöty, H., Lahesmaa, R., Veijola, R., Toppari, J., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1211015 · Cited by 17
Self-citationQuinn, L. M., Dias, R. P., Bidder, C., Bhowmik, S., Bumke, K., Ganapathi, J., Gorman, S., Hind, E., Karandikar, S., Kumar, K. B., et al. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004480 · Cited by 16
Hohenstein, A. C., Gallegos, J. B., Dang, M., Groegler, J., BRONCUCIA, H. C., Tensun, F., Waugh, K., Dong, F., James, E. A., Speake, C., et al. (2025) · Diabetes · doi:10.2337/db24-0611 · Cited by 16
Self-citationNg, K., Anand, V., Stavropoulos, H., Veijola, R., Toppari, J., Maziarz, M., Lundgren, M., Waugh, K., Frohnert, B. I., Martin, F., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05799-y · Cited by 16
Self-citationTemporal Alterations in CD8+ T Cells During the Progression From Stage 1 to Stage 3 Type 1 Diabetes
Schroderus, A., Pitkänen, V., Ekman, I., Stevens, D., Rytkönen-Nissinen, M. A., Rintamäki, R. M., Pihlajamäki, J., Knip, M., Veijola, R., Toppari, J., et al. (2024) · Diabetes · doi:10.2337/db24-0159 · Cited by 15
Self-citationType 1 diabetes: immune pathology and novel therapeutic approaches
Ling, E. M., Lemos, J. R. N., Hirani, K., & von Herrath, M. (2024) · Diabetology International · doi:10.1007/s13340-024-00748-z · Cited by 14
Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering
Mistry, S., Gouripeddi, R., Raman, V. S., & Facelli, J. C. (2022) · Diabetologia · doi:10.1007/s00125-022-05843-x · Cited by 12
Robino, A., Bevilacqua, E., Aldegheri, L., Conti, A., Bazzo, V., Tornese, G., & Catamo, E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1427349 · Cited by 13
Kwon, B. C., Achenbach, P., Anand, V., Frohnert, B. I., Hagopian, W., Hu, J., Koski, E., Lernmark, Å., Lou, O., Martin, F., et al. (2022) · Diabetes · doi:10.2337/db22-0360 · Cited by 11
Self-citationBesser, R. E. J., Campbell, F., Damazer, K., Elleri, D., Gillespie, K. M., Hambling, C. E., Martin, R., Mehta, F., Millar, S., Sachdev, P., et al. (2025) · Diabetic Medicine · doi:10.1111/dme.70117 · Cited by 11
Emerging Concepts and Success Stories in Type 1 Diabetes Research: A Road Map for a Bright Future
Mallone, R., Sims, E. K., Achenbach, P., Mathieu, C., Pugliese, A., Atkinson, M. A., Dutta, S., Evans‐Molina, C., Klatzmann, D., Koralova, A., et al. (2024) · Diabetes · doi:10.2337/db24-0439 · Cited by 11
Self-citationKuusela, S., Koskenniemi, J. J., Valtanen, T., Pokka, T. M.-L., Härkönen, T., Ilonen, J., Lempainen, J., Kyrönniemi, A., Toppari, J., Knip, M., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06573-6 · Cited by 8
Self-citationThe inflammatory path toward type 1 diabetes begins during pregnancy
Ahrens, A. P., Dias, R., Hyötyläinen, T., Orešič, M., Triplett, E. W., & Ludvigsson, J. (2026) · Nature Communications · doi:10.1038/s41467-025-67712-6 · Cited by 8
Cantley, J., Eizirik, D. L., Latres, E., Dayan, C. M., & _, _. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0082 · Cited by 10
Mallone, R., Bismuth, É., Thivolet, C., Benhamou, P., Hoffmeister, N., Collet, F., Nicolino, M. P., Reynaud, R., Beltrand, J., Beltrand, J., et al. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.06.003 · Cited by 11
Ballou, C., Barton, F. B., Payne, E. H., Berney, T., Villard, J., Meier, R. P. H., Baidal, D. A., Alejandro, R., Robien, M. A., Eggerman, T. L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1110544 · Cited by 9
Teplizumab for stage 2 type 1 diabetes: a new era in pediatric diabetes prevention
Zaitoon, D., & Zaitoon, H. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-06520-y · Cited by 7
Schirru, E., Rossino, R., Diana, D., Jores, R. D., Baldera, D., Muntoni, S., Spiga, C., Ripoli, C., Ricciardi, M. R., Cucca, F., et al. (2024) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000710 · Cited by 9
Li, Z., Veijola, R., Koski, E., Anand, V., Martin, F., Waugh, K., Hyöty, H., Winkler, C., Killian, M. B., Lundgren, M., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac121 · Cited by 7
Self-citationHirvonen, M. K., Lietzén, N., Moulder, R., Bhosale, S. D., Koskenniemi, J. J., Vähä-Mäkilä, M., Nurmio, M., Orešič, M., Ilonen, J., Toppari, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-43039-4 · Cited by 7
Self-citationJamiołkowska‐Sztabkowska, M., Noiszewska, K., Polkowska, A., Zasim, A., Trzebuchowski, S., Głowińska‐Olszewska, B., Anikiej, K., Nesterowicz, M., Skorupska, M., Bossowski, F., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16560 · Cited by 6
de Wit, D. F., Snethlage, C. M. F., Minab, R., Rampanelli, E., de Groen, P., Balvers, M., McDonald, T. J., Oram, R. A., Roep, B. O., van Raalte, D. H., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16604 · Cited by 5
Biradar, R., Ullah, U., Lönnberg, T., Junttila, S., Tomi, S., Norman, S. Z., Starskaia, I., Paulin, N., Mikkola, L., Vaarala, O., et al. (2025) · Genome Medicine · doi:10.1186/s13073-025-01574-x · Cited by 5
Self-citationRebalancing the Immune System to Treat Type 1 Diabetes
Müller, Y. D., Ho, P., Bluestone, J. A., & Tang, Q. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041599 · Cited by 5
Optimizing Type 1 Diabetes Screening in People With Family History: A German Perspective
Danne, T., Kapellen, T. M., Widholz, S. A., Wabitsch, M., & Ziegler, R. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251383911 · Cited by 5
Extremely Early Appearance of Islet Autoantibodies in Genetically Susceptible Children
Kyrönniemi, A., Valtanen, T., Koskenniemi, J. J., Vähäsalo, P., Härkönen, T., Ilonen, J., Toppari, J., Knip, M., & Veijola, R. (2023) · Pediatric Diabetes · doi:10.1155/2023/9973135 · Cited by 4
Self-citationGomes, M. B., dos Santos, G. C., Azulay, R. S. D. S., Santos, D. C., Da, S., Carvalho, P. R. V. B., Negrato, C. A., & Pôrto, L. C. (2024) · HLA · doi:10.1111/tan.15574 · Cited by 5
Insulitis and Exocrinitis in Autoantibody-positive Nondiabetic Individuals: Role of HLA Genotypes
Diedisheim, M., Mallone, R., Pugliese, A., Dubois‐Laforgue, D., & Larger, É. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf039 · Cited by 4
Viral infection‐related gene upregulation in monocytes in children with signs of β‐cell autoimmunity
Valta, M., Yoshihara, M., Einarsdóttir, E., Pahkuri, S., Ezer, S., Katayama, S., Knip, M., Veijola, R., Toppari, J., Ilonen, J., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13346 · Cited by 4
Self-citationBombicino, S. S., Trabucchi, A., Sabljic, A. V., Marfía, J. I., Iacono, R. F., & Valdez, S. N. (2025) · European journal of medical research · doi:10.1186/s40001-025-03457-8 · Cited by 3
Statistical Evaluation of Environmental Factors as Diabetogenic Agent in Type 2 Diabetes Mellitus
Shokat, S., Riaz, A., Iqbal, D. R., Yaqub, A., & Riaz, S. (2022) · International Journal of Innovations in Science and Technology · doi:10.33411/ijist/2022040201 · Cited by 3
Martínez-Brocca, M. A., Bellido, V., Cardona-Hernandez, R., Castaño, L., Conget, I., Fernández, A., Gila, A. G. G., Leiva-Gea, I., & Mauricio, D. (2025) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2025.501639 · Cited by 5
Social and ethical implications of screening for type 1 diabetes in the UK
Randell, M. J., Narendran, P., Greenfield, S. M., & Boardman, F. (2026) · JME Practical Bioethics · doi:10.1136/jmepb-2025-000024 · Cited by 2
Chobot, A. P., Bossowski, A. T., Jarosz-Chobot, P. A., Myśliwiec, M., Szadkowska, A., Szypowska, A., & Walczak, M. (2026) · Hormone Research in Paediatrics · doi:10.1159/000551858 · Cited by 2
Evolución de la ginecología peruana al Bicentenario, y el futuro
Rechkemmer, A. F., & Romero, J. P. (2021) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v67i2334 · Cited by 2
Kero, J. T., Koskenniemi, J. J., Karsikas, S., Pokka, T. M.-L., Lou, O., Toppari, J., & Veijola, R. (2022) · Diabetic Medicine · doi:10.1111/dme.14913 · Cited by 2
Self-citationPersonalizing Early-Stage Type 1 Diabetes in Children
Limbert, C., Berge, T. V. D., & Danne, T. (2023) · Diabetes Care · doi:10.2337/dci23-0025 · Cited by 2
Protocol for the development of a core outcome set for type 1 diabetes risk screening
Chen, C., Luca, S., Hansen, A., Wherrett, D. K., Witteman, H. O., Chakraborty, P. K., L’Espérance, A., Wilson, M. G., McGavock, J., Delorme, S., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-099537 · Cited by 2
Martínez-Brocca, M. A., Bellido, V., Cardona-Hernández, R., Castaño, L., Conget, I., Fernández, A., Gila, A. G. G., Leiva-Gea, I., & Mauricio, D. (2025) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endien.2025.501639 · Cited by 3
Impact of Sample Type on ADAP-Based Autoantibody Detection for Type 1 Diabetes Population Screening
Urrutia, I., González-Arceo, M., Calvo, B., Aurrekoetxea, J., Fernández-Rubio, E., Urquijo, V., Bilbao, J. R., Rica, I., Castaño, L. A., Martínez, R., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251390835 · Cited by 1
The First Selective Screening for Type 1 Diabetes in a Pediatric Population in Bulgaria
Yaneva, N., Petrova, M., Yordanova, A., Popov, T. T., Arshinkova, M., Kyurkchiev, D., & Kurteva, E. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15083075 · Cited by 1
Christensen, J. H., Petersen, G. L., Kaur, S., Lind, A., Hamdan, S., Scherman, M. N., Johannesen, J., Agardh, D., Antvorskov, J. C., & Pociot, F. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71194 · Cited by 1
Pediatric diabetes diagnosis: New ISPAD guidelines 2022
Zdravković, V., Ješić, M. D., Bojić, V., Kovačević, S., Blagojević, J., Miolski, J., & Didić, N. (2023) · Galenika Medical Journal · doi:10.5937/galmed2305096z · Cited by 1
Wherrett, D. K. (2021) · Diabetes Care · doi:10.2337/dci21-0018 · Cited by 1
Loss of Exocytosis Protein DOC2B is an Early Event in Type 1 Diabetes DevelopmentPreprint
Esparza, D., Oh, E., Hwang, J. H., Bhowmick, D. C., McCown, E. M., Hacker-Stratton, J., Kandeel, F., Reijonen, H., Hagopian, W., Jovanović‐Talisman, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.28.696610 · Cited by 1
Self-citationRoy, S., Proffer, M. L., Syed, F., Smithmyer, M. E., Sharma, A. R., Twoy, A., Soohoo, E., Rana, J., Spaeth, J. M., Meyer, E. H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.10.705171 · Cited by 1
Self-citationAutoimmune Diseases in Childhood
Karmazsin, L., Péter, F., & Szombathy, G. (2024) · Frontiers research topics · doi:10.3389/978-2-8325-5731-0
Ng, K., Stavropoulos, H., Anand, V., Veijola, R., Toppari, J., Maziarz, M., Lundgren, M., Waugh, K., Frohnert, B. I., Martin, F., et al. (2021) · doi:10.2337/figshare.16826560.v1
Self-citationNg, K., Stavropoulos, H., Anand, V., Veijola, R., Toppari, J., Maziarz, M., Lundgren, M., Waugh, K., Frohnert, B. I., Martin, F., et al. (2021) · doi:10.2337/figshare.16826560
Self-citationSymptomatic Type 1 Diabetes Is Approaching, but When?
Toppari, J., & Veijola, R. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae578
Self-citationMaziarz, M., Koskenniemi, J. J., Martinez, M. M., Spiliopoulos, L., Salami, F., Toppari, J., Kero, J. T., Veijola, R., Tossavainen, P. H., Palmu, S. A., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf073
Self-citationJönsson, J., & Lernmark, Å. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00176-9 · Cited by 1
Self-citationDiabetes mellitus tipo 1: tratamiento y prevención
Romero, P. E. (2025) · Pediatría Integral · doi:10.63149/j.pedint.46
Martínez‐Brocca, M. A., Bellido, V., Cardona‐Hernandez, R., Castaño, L., Conget, I., Fernández, A., Gila, A. L. G., Gea, I. L., & Mauricio, D. (2025) · Anales de Pediatría · doi:10.1016/j.anpedi.2025.503944
Martínez-Brocca, M. A., Bellido, V., Cardona-Hernández, R., Castaño, L., Conget, I., Fernández, A., Gila, A. G. G., Leiva-Gea, I., & Mauricio, D. (2025) · Anales de Pediatría · doi:10.1016/j.anpede.2025.503944
Hirvonen, M. K. (2025) · UTUPub (University of Turku)
Exploring minimally invasive approach to define stages of type 1 diabetes remotely
Alanko, I. (2022) · UTUPub (University of Turku)
Immunological mechanisms in the pathogenesis of type 1 diabetes
Valta, M. (2023) · UTUPub (University of Turku)
Jatkuvan glukoosisensoroinnin tulkinta ja hyödyntäminen kliinisessä työssä
Puuronen, A. (2025) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Spotlight on the Pathology of Type 1 Diabetes
Ling, E. M., Lemos, J. R. N., Quesada‐Masachs, E., Hirani, K., & von Herrath, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00016-0
Abujlambo, A. I., Nabaa, S., Woldemeskel, M., Cutaia, J., Zaidi, M., Ferdous, S., Aung, T., Asfand, S., War, N. N. W., Pulpandi, S., et al. (2026) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-026-00687-y
Oxidative Stress Biomarkers in Pediatric and Early-Stage Type 1 Diabetes: Toward Redox Phenotyping
Mittal, R., Alberti, A., Shivakumar, R., Selvan, L., Gupta, V., Aggarwal, A., Patel, V., Blaschke, C. E., Alipour, F., & Hirani, K. (2026) · Antioxidants · doi:10.3390/antiox15081044
Rigla, M., Fernández-Balsells, M. M., & Wägner, A. M. (2026) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2026.501877
Rigla, M., Fernández-Balsells, M. M., & Wägner, A. M. (2026) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2026.501877
Lestari, S. R., Endaryanto, A., Rochmah, N., & Wungu, C. D. K. (2025) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v96i3.16666
Lehmann, M., Hò, G. T., Augstein, P., Baranowska-Dell, M., Dähnrich, C., Deerberg, A., Saschenbrecker, S., Kerner, W., Komorowski, L., Kühnl, A., et al. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.122866
Metghalchi, S., Jones, A., Bismuth, É., Carel, J., Beltrand, J., Sola‐Gazagnes, A., Larger, É., Morel, N., Gautier, J., Riveline, J., et al. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101797
Schroderus, A., & Kinnunen, T. T. (2024) · ImmPort · doi:10.21430/m3eoyvhu3w
Noiszewska, K., Jamiołkowska‐Sztabkowska, M., Zasim, A., Polkowska, A., Mazur, A., Brzuszek, M., Niechciał, E., Wysocka‐Mincewicz, M., Myśliwiec, M., Szmigiero-Kawko, M., et al. (2026) · Pediatric Diabetes · doi:10.48130/pedi-0026-0012
Younes, Y. R., Besser, R. E. J., Swaby, R., Wilmot, E. G., Wild, S. H., Narendran, P., Gillespie, K. M., Lumb, A. N., Dhatariya, K., Kanumilli, N., et al. (2026) · Diabetic Medicine · doi:10.1111/dme.70528
Metadata
- Authors
- Anand, V., Li, Y., Liu, B., Ghalwash, M., Koski, E., Ng, K., Dunne, J. L., Jönsson, J., Winkler, C., Knip, M., Toppari, J., Ilonen, J., Killian, M. B., Frohnert, B. I., Lundgren, M., Ziegler, A.-G., Hagopian, W., Veijola, R., & Rewers, M.
- Affiliations
- IBM (United States) (US)
- Ain Shams University (EG)
- Breakthrough T1D (US)
- Lund University (SE)
- Helmholtz Munich (DE)
- University of Helsinki (FI)
- University of Turku (FI)
- Pacific Northwest Research Institute, Seattle, WA
- University of Colorado Denver (US)
- Oulu University Hospital (FI)
- Corresponding author
- Anand, Vibha
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-06-23
- Volume
- 44
- Issue
- 10
- Pages
- 2269-2276
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC8929180
- OpenAlex
- W3173682566
- Semantic Scholar
- e861f7aa2426d08c382e76e91205144bdbf4894e
- Cited by
- 83
- References
- 39
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 18 · 2023: 12 · 2022: 13 · 2021: 6
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion, other-oa)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK032493, R01DK026190, R37DK032493, R01DK104351, R37DK032083, P30DK116073, R01DK032083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- islet autoimmunity, islet autoantibodies, seroconversion, HLA markers, disease progression, diabetes risk prediction, children, infants and toddlers, genetic risk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.